Selected article for: "alanine aminotransferase and AST aspartate aminotransferase"
Author: Kang, Soo Jung; Kim, Nam Su
Title: Association of Toll-like receptor 2-positive monocytes with coronary artery lesions and treatment nonresponse in Kawasaki disease
  • Document date: 2017_7_31
    • ID: tk1bxztw_32
    Snippet: As predicted, duration of fever after IVIG treatment was signifi cantly longer in the IVIG nonresponders compared to that in the IVIG responders. Among the parameters that have previously been Values are presented as mean±standard deviation or number (%). CALs (+), patients with coronary artery lesions one month after diagnosis; CALs (-), patients without coronary artery lesions one month after diagnosis; IVIG, intravenous immunoglobulin; WBC, w.....
    Document: As predicted, duration of fever after IVIG treatment was signifi cantly longer in the IVIG nonresponders compared to that in the IVIG responders. Among the parameters that have previously been Values are presented as mean±standard deviation or number (%). CALs (+), patients with coronary artery lesions one month after diagnosis; CALs (-), patients without coronary artery lesions one month after diagnosis; IVIG, intravenous immunoglobulin; WBC, white blood cell; CRP, C-reactive protein; AST, aspartate aminotransferase; ALT, alanine aminotransferase. *P<0.05 when compared with febrile controls.

    Search related documents:
    Co phrase search for related documents
    • alanine aminotransferase and blood cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • alanine aminotransferase and fever duration: 1, 2, 3, 4
    • alanine aminotransferase and intravenous immunoglobulin: 1, 2, 3
    • alanine aminotransferase and IVIG treatment: 1
    • artery lesion and coronary artery lesion: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • artery lesion and febrile control: 1
    • artery lesion and intravenous immunoglobulin: 1, 2, 3, 4, 5
    • artery lesion and IVIG treatment: 1, 2
    • aspartate aminotransferase and blood cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • aspartate aminotransferase and fever duration: 1, 2
    • aspartate aminotransferase and intravenous immunoglobulin: 1, 2
    • aspartate aminotransferase and IVIG treatment: 1
    • blood cell and febrile control: 1
    • blood cell and fever duration: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
    • blood cell and intravenous immunoglobulin: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • blood cell and IVIG treatment: 1, 2, 3, 4
    • blood cell and number deviation: 1
    • coronary artery lesion and intravenous immunoglobulin: 1, 2, 3, 4, 5
    • coronary artery lesion and IVIG treatment: 1, 2